UPDATE : Friday, February 22, 2019
상단여백
Regulator OKs Bukwang’s anticancer treatment by Lee Han-soo 2019-02-22 15:29
Will first-ever treatment for nonalcoholic fatty liver arrive? by Kim Yun-mi 2019-02-22 15:29
Hugel hits record-high quarterly sales by Lee Han-soo 2019-02-22 13:30
Huons posts record-high sales in 2018 by Lee Han-soo 2019-02-21 17:17
Mediforum verifies safety, efficacy of dementia treatment candidate by Lee Han-soo 2019-02-21 15:13
라인
DPP-4 inhibitors raise bullous pemphigoid risk in diabetic patients: study by Kim Yun-mi 2019-02-21 15:13
Xtandi adds indication for non-metastatic castration-resistant prostate cancer by Kim Yun-mi 2019-02-21 15:10
SCM, Allele to develop diabetes treatment by Lee Han-soo 2019-02-21 14:57
Pfizer’s patent barrier foils Korea’s 1st pneumococcal conjugate vaccine by Lee Han-soo 2019-02-20 16:18
FDA rejects Medytox’s ‘citizen petition’ against Daewoong by Lee Han-soo 2019-02-20 14:37
라인
Court suspends FSC’s disciplinary action against Samsung BioLogics by Lee Han-soo 2019-02-20 12:12
Chong Kun Dang unveils trial results for erectile dysfunction treatment by Lee Han-soo 2019-02-19 17:36
Yuhan’s sales reached ₩1.5 trillion in 2018 by Lee Han-soo 2019-02-19 16:06
Pharma Research Bio wins nod to export botulinum toxin by Lee Hye-seon 2019-02-19 15:46
[News Focus] Will MSD’s new antidiabetic SGLT-2 inhibitor prove effective? by Kim Yun-mi 2019-02-19 14:31
라인
Does anticoagulant Eliquis work on children? by Lee Hye-seon 2019-02-19 10:53
Technoclone to supply Handok diagnostic reagent for ADAMTS-13 activity test by Lee Han-soo 2019-02-18 16:38
‘Hair loss drug Propesia works well for Koreans in long term’ by Kim Yun-mi 2019-02-18 16:38
Hanmi’s RaboneD dominates osteoporosis therapy market by Kim Yun-mi 2019-02-18 14:23
Humedix posts record-high sales in Q4 sales by Lee Han-soo 2019-02-18 14:22
여백
여백
여백
Back to Top